Geneviève Deblois and her team aim to better understand the development of drug resistance in cancers, particularly in triple negative breast cancer. They study changes in cell metabolism that contribute to the development of resistance to treatments by modifying the epigenetic profile of cancer cells.
Research topics
-
Cancer Genomics and Epigenetics
Publications
-
October 29, 2024 Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.
Safa-Tahar-Henni S, Páez Martinez K, Gress V, Esparza N, Roques E, Bonnet-Magnaval F, Bilodeau M, Gagné V, Bresson E, Cardin S, El-Hachem N, Iasenza I, Alzial G, Boivin I, Nakamichi N, Soufflet AC, Mirela Pascariu C, Duchaine J, Mathien S, Bonneil E, Eppert K, Marinier A, Sauvageau G, Deblois G, Thibault P, Hébert J, Eaves CJ, Cellot S, Barabé F, Wilhelm B
Leukemia 2024-10-29 ;39( 1 ):29-41 - See all publications
Awards and distinctions
-
Project Grant - Canadian Institutes of Health Research, 2021-2026